Ovid Therapeutics Inc. (OVID)
NASDAQ: OVID · Real-Time Price · USD
1.040
+0.010 (0.97%)
Nov 20, 2024, 4:00 PM EST - Market closed
Ovid Therapeutics Employees
Ovid Therapeutics had 40 employees as of December 31, 2023. The number of employees decreased by 4 or -9.09% compared to the previous year.
Employees
40
Change (1Y)
-4
Growth (1Y)
-9.09%
Revenue / Employee
$15,792
Profits / Employee
-$812,549
Market Cap
73.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
P3 Health Partners | 400 |
Rockwell Medical | 237 |
Exagen | 179 |
VolitionRx | 110 |
Scilex Holding Company | 105 |
BioAtla | 65 |
Werewolf Therapeutics | 47 |
PDS Biotechnology | 25 |
OVID News
- 2 months ago - Meg Alexander Takes on Expanded Role as President and COO at Ovid Therapeutics, Strengthening Leadership for Future Growth - GlobeNewsWire
- 3 months ago - Shareholders In Ovid Therapeutics Inc Invited To Participate In Fraud Investigation With The Schall Law Firm - Accesswire
- 3 months ago - Ovid Therapeutics Inc Investors Encouraged To Join Fraud Investigation With Schall Law Firm - Accesswire
- 3 months ago - Ovid Therapeutics Inc Shareholders Eligible To Participate In Fraud Investigation With Schall Law Firm - Accesswire
- 3 months ago - Ovid Therapeutics Inc Investors Invited To Join In Fraud Investigation With Schall Law Firm - Accesswire
- 3 months ago - Ovid Therapeutics Inc Shareholders Encouraged To Join Fraud Investigation With Schall Law Firm - Accesswire
- 3 months ago - Ovid Therapeutics Inc Shareholders Invited To Join Fraud Investigation With Schall Law Firm - Accesswire
- 3 months ago - Ovid Therapeutics Inc Investors Welcome To Participate In Fraud Investigation With Schall Law Firm - Accesswire